Molecular Virology

Molecular Virology

Author: Susanne Modrow

Publisher: Springer

Published: 2013-09-18

Total Pages: 0

ISBN-13: 9783642207174

DOWNLOAD EBOOK

The book gives a comprehensive overview on the knowledge of virus infection relevant for humans and animals. For each virus family the molecular details of the virus particle and the viral replication cycle are described. In the case of virus types with relevance for human and/or animal health the data on molecular biology, genetics and virus-cell interaction are combined with those concerning, pathogenesis, epidemiology, clinics, prevention and therapy.


Dynamics of Positive-strand RNA Viruses

Dynamics of Positive-strand RNA Viruses

Author: Huicheng Shi

Publisher:

Published: 2021

Total Pages: 89

ISBN-13:

DOWNLOAD EBOOK

A major impact of viruses on humans is that they cause a variety of diseases including AIDS, flu, cancer, the common cold, and most recently, COVID-19. For many of the diseases, there are no vaccines or treatments. To develop the therapeutics, it is necessary to understand the growth of viruses in their native environment, host cells. The complexity of this environment adds difficulties to the comprehension of the viruses. Most research efforts focus on the molecular mechanisms behind the virus-host cell interactions and organ or the clinical level response of infected subjects, but relatively less attention has been paid to the middle of the spectrum, the spread of virus infection over multiple infection cycles, especially in a manner that is both dynamic and quantitative. To help mitigate the gap in our knowledge, we develop here experimental and computational methods to research the viral dynamics of two positive-strand RNA viruses within and beyond the single cycle.First, viral protein expression dynamics were measured utilizing a recombinant reporter strain of human rhinovirus A16 (RV-A16) infecting HeLa cells as an example. Rhinovirus is a positive-strand RNA virus, and its infection causes the common cold, which is frequent in both adults and children. No antiviral has been approved to treat rhinovirus infection, so researchers are interested in host factors involved in rhinovirus infection as potential therapeutic targets. In our study, infected cells were automatically imaged over time to detect the fluorescence level from the reporter virus, which is a measurement of viral protein expression. A set of parameters were defined to describe the timing and magnitude of the viral protein expression dynamics. The numbers of fluorescent positive cells detected in the same frames over differently treated cells depict the susceptibility under different conditions. Cells treated with a translation inhibitor had a lower susceptibility and those that were infected were slower in the timing of viral protein expression. Cells in different stages of the cell cycle were similarly susceptible to infection and displayed similar viral protein dynamics. Serum starvation reduced the susceptibility but did not change the viral protein expression in the first cycle of infection. However, for the second cycle, the infection in serum-starved cells was earlier. If the mechanisms behind the serum related phenomena can be identified, drugs to promote resistance to or slow the spread of rhinovirus might be discovered. The discovery of the phenomena would not be possible without the study of the multi-cycle dynamics of the rhinovirus with this reporter strain. The second example was the single-cycle and multi-cycle virus growth dynamics of another positive-strand RNA virus, the Zika virus. We are concerned about the Zika virus because its infection in pregnant women increases the risk of defects in newborns. Two strains of the Zika virus that belong to different lineages were used to infect the Vero cells respectively. Their infection dynamics not only characterize the distinction between the two lineages but also help identify optimization strategies for vaccine production. In single-cycle infections, the infection of African strain resulted in slower virus production till 20 hours post-infection (h.p.i.) but higher final virus titer. These agree with the viral protein expression measured by immunocytochemical staining and fluorescent microscopy that cells infected by the African strain had a lower fluorescent positive rate and a lower mean intensity at the early stage. For multi-cycle infections, both strains had similar dynamics, but the African strain had a higher titer. The African strain had a lower extracellular degradation rate in comparison to the Asian strain. Finally, the growth curves of the Zika virus were fitted by ordinary differential equation (ODE) models using three models of delay: fixed, exponential-distributed, and gamma-distributed. For single-cycle growth, the fixed delay model recapitulated the growth of both strains without contradicting cell death curves. The models did not perform ideally for multi-cycle growth. The fixed and exponential-distributed delay models worked the best for the African and the Asian strains, respectively. Sensitivity analysis revealed that changing the degradation of the virus has the largest effect on the titer, which is worth noticing in vaccine production. The models promote our comprehension of the growth kinetics of the Zika virus and can be applied to understand the effect of antivirals and optimize vaccine production processes. Overall, the methods here demonstrated the potential of image-based quantitative measurements and mathematical models in analyzing single-cycle and multi-cycle positive-strand RNA virus infection. This work also provides a basis for further quantitative studies of virus-host interaction at the tissue level.


Negative Strand RNA Virus

Negative Strand RNA Virus

Author: Ming Luo

Publisher: World Scientific

Published: 2011

Total Pages: 323

ISBN-13: 9814317233

DOWNLOAD EBOOK

Ch. 1. Overview of negative-strand RNA viruses / Biao He -- ch. 2. Rhabdovirus entry into the host cell / Aurelie Albertini and Yves Gaudin -- ch. 3. Virus entry : parainfluenza viruses / Masato Tsurudome -- ch. 4. What controls the distinct VSV RNA synthetic processes of replication and transcription? / Gail Williams Wertz, Summer E. Galloway and Djamila Harouaka -- ch. 5. mRNA capping by vesicular stomatitis virus and other related viruses / Tomoaki Ogino and Amiya K. Banerjee -- ch. 6. Structural disorder within the measles virus nucleoprotein and phosphorprotein : functional implications for transcript and replication / Sonia Longhi -- ch. 7. Biochemical and structural insights into vesicular stomatitis virus transcription / Amal A. Rahmeh and Sean P.J. Whelan -- ch. 8. Transcription of vesicular stomatitis virus RNA genome / Debasis Panda and Asit K. Pattnaik -- ch. 9. Assembly of vesicular stomatitis virus / Ming Luo, Todd J. Green and Z. Hong Zhou -- ch. 10. Paramyxovirus budding mechanisms / Megan S. Harrison, Takemasa Sakaguchi and Anthony P . Schmitt -- ch. 11. Virus-host interaction by members of the family rhabdoviridae and filoviridae / Douglas S. Lyles -- ch. 12. Paramyxovirus and rig-like helicases : a complex molecular interplay driving innate immunity / Denis Gerlier -- ch. 13. The molecular and cellular biology of emerging bunyaviruses / John N. Barr -- ch. 14. Ebolaviruses : what we know and where we are on potential therapeutics / Peter Halfmann, Gabriele Neumann and Yoshihiro Kawaoak


Vaccines for Cancer Immunotherapy

Vaccines for Cancer Immunotherapy

Author: Nima Rezaei

Publisher: Academic Press

Published: 2018-10-17

Total Pages: 200

ISBN-13: 0128140402

DOWNLOAD EBOOK

Therapeutic cancer vaccines represent a type of active cancer immunotherapy. Clinicians, scientists, and researchers working on cancer treatment require evidence-based and up-to-date resources relating to therapeutic cancer vaccines. Vaccines for Cancer Immunotherapy provides a reference for cancer treatment for clinicians and presents a well-organized resource for determining high-potential research areas. The book considers that this promising modality can be made more feasible as a treatment for cancer. Chapters cover cancer immunology, general approaches to cancer immunotherapy, vaccines, tumor antigens, the strategy of allogeneic and autologous cancer vaccines, personalized vaccines, whole-tumor antigen vaccines, protein and peptide vaccines, dendritic cell vaccines, genetic vaccines, candidate cancers for vaccination, obstacles to developing therapeutic cancer vaccines, combination therapy, future perspectives and concluding remarks on therapeutic cancer vaccines. Introduces the feasible immunotherapeutic vaccines for patients with different types of cancer Presents the status of past and current vaccines for cancer treatment Considers advantages and disadvantages of different therapeutic cancer vaccines Looks at the combination of vaccines and other modalities, including immunotherapeutic and conventional methods Analyzes obstacles to development of therapeutic cancer vaccines Gives a view on future perspectives in the application of therapeutic cancer vaccines


Synthetic mRNA

Synthetic mRNA

Author: Robert E. Rhoads

Publisher: Humana

Published: 2016-05-29

Total Pages: 0

ISBN-13: 9781493936236

DOWNLOAD EBOOK

This volume presents detailed laboratory protocols for in vitro synthesis of mRNA with favorable properties, its introduction into cells by a variety of techniques, and the measurement of physiological and clinical consequences such as protein replacement and cancer immunotherapy. Synthetic techniques are described for structural features in mRNA that provide investigational tools such as fluorescence emission, click chemistry, photo-chemical crosslinking, and that produce mRNA with increased stability in the cell, increased translational efficiency, and reduced activation of the innate immune response. Protocols are described for clinical applications such as large-scale transfection of dendritic cells, production of GMP-grade mRNA, redirecting T cell specificity, and use of molecular adjuvants for RNA vaccines. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Synthetic mRNA: Production, Introduction into Cells, and Physiological Consequences is a valuable and cutting-edge resource for both laboratory investigators and clinicians interested in this powerful and rapidly evolving technology.


Pandemic Outbreaks in the 21st Century

Pandemic Outbreaks in the 21st Century

Author: Buddolla Viswanath

Publisher: Elsevier

Published: 2021-08-24

Total Pages: 326

ISBN-13: 0323900011

DOWNLOAD EBOOK

In the past two decades, several pandemics have ravaged the globe, giving us several lessons on infectious disease epidemiology, the importance of initial detection and characterization of outbreak viruses, the importance of viral epidemic prevention steps, and the importance of modern vaccines. Pandemic Outbreaks in the Twenty-First Century: Epidemiology, Pathogenesis, Prevention, and Treatment summarizes the improvements in the 21st century to overcome / prevent / treat global pandemic with future prospective. Divided into 9 chapters, the book begins with an in-depth introduction to the lessons learned from the first pandemic of the 21st century. It describes the history, present and future in terms of detection, prevention and treatment. Followed by chapters on the outbreak, treatment strategies and clinical management of several infectious diseases like MERS, SARD and COVID 19, Pandemic Outbreaks in the Twenty-First Century: Epidemiology, Pathogenesis, Prevention, and Treatment, presents chapters on immunotherapies and vaccine technologies to combat pandemic outbreak and challenges. The book finishes with a chapter on the current knowledge and technology to control pandemic outbreaks. All are presented in a practical short format, making this volume a valuable resource for very broad academic audience. Provides insight to the lessons learned from past pandemics Gives recommendations, future direction in terms of detection, prevention and treatment of pandemics Guides readers through the status and recent developments of vaccines to overcome or prevent pandemics Shows how to enhance the host innate immunity in infectious diseases Includes a chapter on immunotherapies to combat pandemic outbreaks


Peste des Petits Ruminants Virus

Peste des Petits Ruminants Virus

Author: Muhammad Munir

Publisher: Springer

Published: 2016-08-23

Total Pages: 0

ISBN-13: 9783662523087

DOWNLOAD EBOOK

This book offers a timely and comprehensive review of essential research on Peste des Petits Ruminants Virus (PPRV), ranging from its historical distribution, molecular epidemiology, genome structure, viral proteins, immunity, viral pathogenesis, clinical and molecular diagnosis to advances in vaccine developments and future challenges. PPRV, a Rinderpest-like virus, is the causative agent of one of the most rapidly emerging viral diseases among domestic small ruminants, and the host spectrum has now been expanded to wild small ruminants and camels. With the global eradication of the first livestock disease, Rinderpest, attention is now turning to repeating the procedure for PPR. Each of the book’s 13 chapters is dedicated to a specific topic, providing up-to-date literature and discussions by renowned scientists who have made seminal contributions in their respective fields of expertise. Special emphasis has been placed on the analysis of different global efforts to eradicate PPR. This book offers a valuable reference source for virologists, field veterinarians, infection and molecular biologists, immunologists, scientists in related fields and veterinary school libraries.


RNA Viruses

RNA Viruses

Author: Decheng Yang

Publisher: World Scientific

Published: 2009

Total Pages: 722

ISBN-13: 981283379X

DOWNLOAD EBOOK

This is the first comprehensive book on human/animal gene responses to RNA viral infections, including prevalent, emerging and re-emerging RNA viruses such as HIV, SARS-CoV, West Nile virus, influenza virus and many others. Human gene responses are reviewed by leading virologists worldwide in the following aspects: (i) the altered gene expression profiles at the transcriptional and translational levels detected with cutting-edge technologies such as cDNA microarray and proteomics; (ii) host innate and adapted immune responses to viral replication in target organs; (iii) virus-activated signal transduction pathways in cell survival, apoptosis and autophagosomal pathways; and (iv) the small interfering RNA/microRNA-mediated gene silencing pathway, a recently characterized new host defense mechanism against viral infection. Organized into 29 highly accessible and well-illustrated chapters, this volume explores state-of-the-art knowledge of the molecular mechanisms of RNA virus infection and host?virus interactions. This comprehensive compilation of the altered gene expression profiles and signal transduction pathways in host cells in response to the majority of human/animal RNA viruses opens new directions for basic and clinical research on viral pathogenesis, and also provides valuable biomarkers for researchers to select gene targets in the development of diagnostic tests and antiviral therapeutics for a number of infectious diseases.